Significant haematological alterations in clozapine-treated patients: prevalence and clinical correlation
The study's results underscore the necessity of regular haematological monitoring to mitigate the risks of clozapine therapy while leveraging its therapeutic benefits. Additionally, the study suggests personalised dosing strategies to balance efficacy and safety, particularly in managing clozapine-induced haematological changes.
Authors
- Mehmet Gürkan Gürok (ORCID: https://orcid.org/0000-0001-8998-0743)
- Muhammed Fatih Tabara (ORCID: https://orcid.org/0000-0002-7479-5622)
- Murad Atmaca (ORCID: https://orcid.org/0000-0003-2772-4124)
- Cafer Baris Akar
- Mehmet Kadir Atdagi
Institutions
- Fırat University (TR)
Publication Details
- Journal
- Acta Neuropsychiatrica
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1017/neu.2024.54
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00